Across TCGA pan-cancer cohorts, GTF3AP5 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of GTF3AP5’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where GTF3AP5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GTF3AP5 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

KIRC and THCA are the cancer types where GTF3AP5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GTF3AP5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.016	.008	2	view →
THCA	All	All	−0.011	.017	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: GTF3AP5 RNA expression & survival · all GTF3AP5 data types